BOLNO PAUL 4
4 · Wave Life Sciences Ltd. · Filed Mar 7, 2025
Insider Transaction Report
Form 4
BOLNO PAUL
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Share Option (right to buy)
2025-03-07−120,966→ 0 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (120,966 underlying) - Sale
Ordinary Shares
2025-03-07$9.57/sh−169,025$1,617,569→ 338,351 total - Exercise/Conversion
Ordinary Shares
2025-03-07$2.48/sh+169,025$419,182→ 507,376 total - Exercise/Conversion
Share Option (right to buy)
2025-03-07−48,059→ 0 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (48,059 underlying)
Footnotes (3)
- [F1]The options reported in this Form 4 were set to expire on Monday, March 10, 2025. The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2024.
- [F2]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $9.12 to $10.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]These share options are fully vested and have an expiration date of Monday, March 10, 2025.